Our results indicate that, with minimal toxicity, the combination of TAB004 + Lip-MSA-IL-2 was associated with improved survival in the orthotopic murine model of PDA, as well as a lower cancer burden in the PDA.MUC1 mouse spontaneous model of PDA. This evidence concerns the gene IL2 and Patent ductus arteriosus.